businessfortnight

Mumbai, March , 2019:  For the fifth consecutive year, a global collaboration across 80 stock exchanges around the world plan to ‘Ring the Bell for Gender Equality’, to celebrate International Women’s Day 2019 (Friday, 8 March 2019). The events are a partnership between IFC, Sustainable Stock Exchanges (SSE) Initiative, UN Global Compact, UN Women, the World Federation of Exchanges and Women in ETFs, to raise awareness about the business case for women’s economic empowerment and the opportunities for the private sector to advance gender equality and sustainable development. NSE joins Global Exchanges in Ringing the Bell for Gender Equality As part of the events, participants are encouraged to make commitments to improve gender equality in their market, encourage implementation of the Women’s Empowerment Principles (WEPs), a joint initiative between UN Women and the UN Global Compact that provides holistic guidance to business on empowering women. NSE invited the women leaders from NSE

The member nations of RCEP bloc must empower their negotiators to adopt flexibility for resolving pending issues coming in the way of concluding the negotiations for the proposed mega trade agreement, Union Commerce Minister Suresh Prabhu said on March 2. The proposed mega trade deal, Regional Cooperation for Economic Partner (RCEP) agreement, is being negotiated by 16 countries — 10-member Asean group and India, Japan, China, South Korea, Australia and New Zealand. “We should empower our negotiators with mandate to show flexibilities and accommodation on outstanding and pending issues,” Prabhu said at the RCEP ministerial meeting at Siem Reap In Cambodia. He said that a lot of ground still needs to be covered this year “We should be mindful of the limitations ahead, given that there are only three more rounds this year at the technical level,” he said. So far 25 rounds of talks have been concluded but the members have yet to finalise the number of goods on which customs duty will be

China said on March 2 that it welcomed the release of language from the United State Trade Representative’s office (USTR) delaying a scheduled hike in US tariffs on $200 billion worth of Chinese goods. In a statement posted on the website of the Ministry of Commerce, citing an unidentified official at China’s State Council Tariff Commission, China said that it was aware of the USTR’s announcement to maintain tariffs at 10 percent until further notice, and welcomed the step. China says it welcomes delay on US tariff increase The USTR released language to delay a scheduled hike in tariffs on Chinese goods from 10 percent to 25 percent on Friday, ahead of the publication of a notice next Tuesday. President Donald Trump had announced the delay on Sunday as trade talks between the two sides had made progress. source: moneycontrol

The fourth edition of India Pharmaceutical Forum, held this week in Mumbai, that brings together industry leaders, regulators, and quality heads of various companies on a single platform was conspicuous with the absence of one person, who was ubiquitous and the driving force behind the industry’s most important calendar event. Weekly wrap: Indian pharma loses its powerful voice with demise of DG Shah That person is Dilip G Shah, the Secretary General of Indian Pharmaceutical Alliance (IPA), who passed away last week. Shah who was fondly called as ‘DG’, left the industry colleagues and journalists who interacted closely with him in a state of shock. The 77-year old Shah, who graduated from IIM – Ahmedabad, had a long stint at Warner-Lambert, which was later acquired by US drug giant Pfizer. In 1997, after 31 years of service, he took early retirement to start Vision Consulting Group to assist companies in evolving investor-friendly public policies and facilitate market share expansion.

Shilpa Medicare on Monday said it has received approval from the US health regulator for Gemcitabine for injection, used for treatment of various types of cancers. The approved product is a generic equivalent of reference listed drug Gemzar. The company has received US Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA), Gemcitabine for injection USP in the strengths of 200 mg/vial and 1 g/vial, Shilpa Medicare said in a BSE filing. Gemcitabine for injection USP is used in the treatment of ovarian cancer, breast cancer, non-small cell lung cancer and pancreatic cancer. Shilpa Medicare gets USFDA nod for cancer drug Quoting IQVIA MAT data for December 2018, Shilpa Medicare said, the US market for Gemcitabine for injection USP, 200 mg/vial and 1 g/vlal is approximately USD 11.7 million. Shares of Shilpa Medicare were trading 2.19 percent up at Rs 359 apiece on BSE. source: moneycontrol

New Delhi, 22 February 2019:   MobiKwik , India’s largest digital financial services platform, today announced the launch of digital life insurance on its app to its users. MobiKwik in association with ICICI Prudential Life Insurance Company has rolled out first-of-its-kind group micro insurance product. The offering begins with a life cover of Rs. 1 lakh available for a monthly premium as low as Rs. 20/-. This is the second big announcement by MobiKwik in the digital insurance space, post the launch of accidental insurance in November 2018. MobiKwik offers Instant Life Insurance for Rs 20 on its App  The users have an option to choose from three sum assured policies: Rs 1 lakh, 1.5 lakhs and 2 lakhs, available against monthly premiums of Rs 20/-, 30/- and 40/- respectively. Life insurance can be digitally purchased on the MobiKwik app, via a paperless, 2-step process that takes 10 seconds and the policy is issued instantly. MobiKwik will be extending its base of insurance providers i

New Delhi:  The Indian Railways Catering and Tourism Corporation (IRCTC) has finally opened booking for Train 18 or the Vande Bharat Express. People have been eagerly waiting to travel in India’s fastest train, touted as the new Shatabdi Express. Tickets can be bought over the counter or on irctc.co.in. Train 18, which will run between Delhi and Varanasi, will be flagged off by PM Narendra Modi on 15 February but its commercial run will begin from 17 February. Reservations for Delhi Varanasi Train 18 start: 10 things to know 1. New Delhi-Varanasi Vande Bharat Express will depart from the national capital at 6 am and reach Varanasi at 2 pm. On the same day it will depart from Varanasi at 3pm and reach Delhi at 11 pm. 2. The Vande Bharat Express will operate on five days in a week, except on Monday and Thursday. Vande Bharat (Train 18) train at Varanasi Railway Junction, Photo: PTI 3. From Delhi to Varanasi an air-conditioned chair car ticket will cost  ₹ 1,760 and the executive class